权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Novel Methods for Evaluating the Association of Electronic Cigarette Use with Cardiovascular Health

评估电子烟使用与心血管健康关联的新方法

基本信息

批准号：
10462491
负责人：
Andrew Stokes
金额：
$ 17.83万
依托单位：
BOSTON UNIVERSITY MEDICAL CAMPUS
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-08-01 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10462491
关键词：
Abstinence Acute Adult Aerosols Applications Grants Aromatic Polycyclic Hydrocarbons Behavior Biological Markers Biometry Blood Pressure Cardiovascular system Characteristics Cholesterol Cigar Cigarette Clinical Clinical Sciences Consequentialism Coronary heart disease Data Data Science Data Set Development Diagnosis Electronic cigarette Etiology Event Family Frequencies Funding Future Goals Health Health Professional Heart failure In Vitro Inflammation Institutes Intervention Knowledge Label Link Long-Term Effects Measures Mediating Mediation Mediator of activation protein Mentored Research Scientist Development Award Mentors Mentorship Metals Methods Modeling Myocardial Infarction National Health and Nutrition Examination Survey Nicotine Nitrosamines Outcome Oxidative Stress Patient Self-Report Pattern Policies Population Population Assessment of Tobacco and Health Population Research Probability Program Development Prospective cohort study Randomized Controlled Trials Research Research Personnel Residual state Risk Risk Factors Role Safety Sample Size Scientist Secure Series Smokeless Tobacco Statistical Methods Stroke Structural Models Testing Thrombosis Time Tobacco Tobacco use Training Training Activity Translational Research Triglycerides United States Food and Drug Administration United States National Institutes of Health Work base biomarker signature cardiovascular disorder epidemiology cardiovascular effects cardiovascular health cardiovascular injury cardiovascular risk factor career cigarette smoking cigarillos design e-cigarette aerosols early-career faculty electronic cigarette use evidence base high risk population in vivo innovation multidisciplinary non-cigarette tobacco product novel population based population health pre-clinical programs public health intervention skills tobacco products tobacco regulatory science urinary volatile organic compound

项目摘要

Project Summary This proposed 5-year study brings together Dr. Stokes’ training in population health and research on tobacco use behaviors with additional training in tobacco regulatory science, cardiovascular (CV) epidemiology, advanced biostatistics, and applied data science. To this end, Dr. Stokes has assembled a multidisciplinary team of mentors and advisors to aid his training and studies. The K01 will support a complementary set of training activities, including formal coursework, participation in the Early Career Faculty Development Program, the NIH-funded Clinical and Translational Science Institute sponsored K-to-R PRIME program, and strong mentorship from experts in relevant fields, to help him in his professional development and transition to independence. Population-based evidence on the CV effects of e-cigarette use is sparse, and the particular components of e-cigarette aerosols that may be responsible for CV harm remain poorly elucidated. The proposed research will integrate state-of-the-art causal inference methods, mediation analyses, and unsupervised data clustering approaches with the study of CV effects of e-cigarette use. The applicant will 1) examine the association of e-cigarette use and product transitions with incident CV events; 2) estimate associations of e-cigarette use with risk factors and preclinical biomarkers of CV injury, and analyze biomarkers of exposure as potential mediators; and 3) identify unique biomarker signatures of e-cigarette exposure using a data-driven clustering approach, and associate clusters with preclinical biomarkers of CV injury. With high quality population data and novel statistical methods to optimally control for cigarette smoking and other tobacco product use, the results of this project will provide timely and rigorous evidence on the CV effects of e-cigarette use. Together with evaluating the mediating role of exposure biomarkers and clustered e- cigarette use behavior patterns, the results will inform Food and Drug Administration regulatory standards for product safety and guide primary and secondary public health interventions that aim to reduce tobacco-related CV harm. The methods and findings will also inform future studies focused on other non-cigarette tobacco products, such as little cigars, cigarillos, and smokeless tobacco products. The additional training and protected time afforded by the K01 will aid Dr. Stokes in making his transition to an independent investigator capable of securing R-series NIH funding.

项目总结